ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 080,15
0,21%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Crescita Therapeutics Inc (CTX)

  7. Crescita Therapeutics Inc (CTX) Actualités

CTX

Crescita Therapeutics (CTX)

Crescita Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:CTX
DateHeureSourceTitreSymboleSociété
01/06/202311h00PR Newswire (Canada)Croma-Pharma: Launch of topical anaesthetic Pliaglis® in EuropeTSX:CTXCrescita Therapeutics Inc
21/01/202113h30PR Newswire (US)Crescita Announces Filing of New Medical Device LicenseTSX:CTXCrescita Therapeutics Inc
26/11/202013h30PR Newswire (Canada)Crescita Therapeutics Announces Approval of Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
12/11/202013h30PR Newswire (Canada)Crescita Reports Third Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
05/11/202013h30PR Newswire (Canada)Crescita Announces Licensing Agreement for Pliaglis® in ChinaTSX:CTXCrescita Therapeutics Inc
12/08/202013h30PR Newswire (US)Crescita Reports Second Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
28/07/202013h30PR Newswire (US)Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing AgreementTSX:CTXCrescita Therapeutics Inc
27/05/202013h30PR Newswire (US)Crescita Reports First Quarter 2020 ResultsTSX:CTXCrescita Therapeutics Inc
14/05/202014h30PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
28/04/202023h58PR Newswire (US)Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19TSX:CTXCrescita Therapeutics Inc
25/03/202000h23PR Newswire (US)Crescita Therapeutics Announces Measures in Response to COVID-19 VirusTSX:CTXCrescita Therapeutics Inc
18/03/202012h30PR Newswire (US)Crescita Reports Q4 and Fiscal 2019 ResultsTSX:CTXCrescita Therapeutics Inc
10/03/202014h30PR Newswire (Canada)Pliaglis® finally available in CanadaTSX:CTXCrescita Therapeutics Inc
10/03/202014h30PR Newswire (Canada)Pliaglis® enfin disponible au CanadaTSX:CTXCrescita Therapeutics Inc
11/02/202013h30PR Newswire (US)Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patien...TSX:CTXCrescita Therapeutics Inc
24/01/202013h30PR Newswire (US)Crescita Awarded Cannabis Research License from Health CanadaTSX:CTXCrescita Therapeutics Inc
22/01/202013h30PR Newswire (US)Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics LoanTSX:CTXCrescita Therapeutics Inc
20/01/202013h30PR Newswire (US)Crescita Signs Exclusive Distribution Agreement with FILLMEDTSX:CTXCrescita Therapeutics Inc
07/11/201913h30PR Newswire (US)Crescita Reports 2019 Third Quarter ResultsTSX:CTXCrescita Therapeutics Inc
06/11/201900h26PR Newswire (US)U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
28/10/201912h30PR Newswire (US)Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp TopicalsTSX:CTXCrescita Therapeutics Inc
05/09/201913h00PR Newswire (Canada)Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York CityTSX:CTXCrescita Therapeutics Inc
08/08/201913h30PR Newswire (US)Crescita Reports Profitable 2019 Second Quarter ResultsTSX:CTXCrescita Therapeutics Inc
16/07/201913h30PR Newswire (Canada)United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®TSX:CTXCrescita Therapeutics Inc
11/07/201913h30PR Newswire (US)Crescita Therapeutics to Host Investor Webcast on July 24, 2019TSX:CTXCrescita Therapeutics Inc
04/07/201913h30PR Newswire (Canada)Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of ...TSX:CTXCrescita Therapeutics Inc
18/06/201902h17PR Newswire (US)Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer BidTSX:CTXCrescita Therapeutics Inc
30/05/201914h00PR Newswire (US)Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, CaliforniaTSX:CTXCrescita Therapeutics Inc
29/05/201914h00PR Newswire (US)Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications ServicesTSX:CTXCrescita Therapeutics Inc
15/05/201914h31PR Newswire (US)Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of ShareholdersTSX:CTXCrescita Therapeutics Inc
 Showing the most relevant articles for your search:TSX:CTX

Dernières Valeurs Consultées

LSE
3NFE
Ls 3x Netflix
ASX
DNA
Donaco
BFNX
SANETH
COIN
DANGBP
ASX
JHGKOD
GATE
BGTUSDT
BG Trade
TSX
EXE
Extendicare
LSE
34UD
Anglo Am. 50a
COIN
LAIKAUSD
laika
USOTC
AEWRF
Aew Uk Reit (PK)
ASX
ACM
Australian Critical Mine...
ASX
INHHC
Interstar Mill SR064H
USOTC
UOLGF
UOL (PK)
USOTC
SRKZF
Sky Gold (PK)
ASX
DXSSSE
BIT
AIGC
ETFS All Commodities
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés